Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance
Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance(IR). Macrophages infiltrate the adipose tissue(AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltrat...
Saved in:
Published in | World journal of diabetes Vol. 8; no. 3; pp. 97 - 103 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
15.03.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1948-9358 1948-9358 |
DOI | 10.4239/wjd.v8.i3.97 |
Cover
Abstract | Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance(IR). Macrophages infiltrate the adipose tissue(AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltration is regulated by the chemokines that are released from hypertrophied adipocytes and the immune cells in AT. Saturated fatty acids are recognized by toll-like receptor 4(TLR4) and induce inflammatory responses in AT macrophages(ATMs). The inflammatory cytokines that are released from activated ATMs promote IR in peripheral organs, such as the liver, skeletal muscle and AT. Therefore, ATM activation is a therapeutic target for IR in obesity. The ubiquitin ligase Casitas b-lineage lymphoma-b(Cbl-b) appears to potently suppress macrophage migration and activation. Cbl-b is highly expressed in leukocytes and negatively regulates signals associated with migration and activation. Cbl-b deficiency enhances ATM accumulation and IR in aging- and diet-induced obese mice. Cbl-b inhibits migration-related signals and SFA-induced TLR4 signaling in ATMs. Thus, targeting Cbl-b may be a potential therapeutic strategy to reduce the IR induced by ATM activation. In this review, we summarize the regulatory functions of Cbl-b in ATMs. |
---|---|
AbstractList | Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance (IR). Macrophages infiltrate the adipose tissue (AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltration is regulated by the chemokines that are released from hypertrophied adipocytes and the immune cells in AT. Saturated fatty acids are recognized by toll-like receptor 4 (TLR4) and induce inflammatory responses in AT macrophages (ATMs). The inflammatory cytokines that are released from activated ATMs promote IR in peripheral organs, such as the liver, skeletal muscle and AT. Therefore, ATM activation is a therapeutic target for IR in obesity. The ubiquitin ligase Casitas b-lineage lymphoma-b (Cbl-b) appears to potently suppress macrophage migration and activation. Cbl-b is highly expressed in leukocytes and negatively regulates signals associated with migration and activation. Cbl-b deficiency enhances ATM accumulation and IR in aging- and diet-induced obese mice. Cbl-b inhibits migration-related signals and SFA-induced TLR4 signaling in ATMs. Thus, targeting Cbl-b may be a potential therapeutic strategy to reduce the IR induced by ATM activation. In this review, we summarize the regulatory functions of Cbl-b in ATMs. Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance (IR). Macrophages infiltrate the adipose tissue (AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltration is regulated by the chemokines that are released from hypertrophied adipocytes and the immune cells in AT. Saturated fatty acids are recognized by toll-like receptor 4 (TLR4) and induce inflammatory responses in AT macrophages (ATMs). The inflammatory cytokines that are released from activated ATMs promote IR in peripheral organs, such as the liver, skeletal muscle and AT. Therefore, ATM activation is a therapeutic target for IR in obesity. The ubiquitin ligase Casitas b-lineage lymphoma-b (Cbl-b) appears to potently suppress macrophage migration and activation. Cbl-b is highly expressed in leukocytes and negatively regulates signals associated with migration and activation. Cbl-b deficiency enhances ATM accumulation and IR in aging- and diet-induced obese mice. Cbl-b inhibits migration-related signals and SFA-induced TLR4 signaling in ATMs. Thus, targeting Cbl-b may be a potential therapeutic strategy to reduce the IR induced by ATM activation. In this review, we summarize the regulatory functions of Cbl-b in ATMs.Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance (IR). Macrophages infiltrate the adipose tissue (AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltration is regulated by the chemokines that are released from hypertrophied adipocytes and the immune cells in AT. Saturated fatty acids are recognized by toll-like receptor 4 (TLR4) and induce inflammatory responses in AT macrophages (ATMs). The inflammatory cytokines that are released from activated ATMs promote IR in peripheral organs, such as the liver, skeletal muscle and AT. Therefore, ATM activation is a therapeutic target for IR in obesity. The ubiquitin ligase Casitas b-lineage lymphoma-b (Cbl-b) appears to potently suppress macrophage migration and activation. Cbl-b is highly expressed in leukocytes and negatively regulates signals associated with migration and activation. Cbl-b deficiency enhances ATM accumulation and IR in aging- and diet-induced obese mice. Cbl-b inhibits migration-related signals and SFA-induced TLR4 signaling in ATMs. Thus, targeting Cbl-b may be a potential therapeutic strategy to reduce the IR induced by ATM activation. In this review, we summarize the regulatory functions of Cbl-b in ATMs. |
Author | Tomoki Abe Katsuya Hirasaka Takeshi Nikawa |
AuthorAffiliation | Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School;Graduate School of Fisheries Science and Environmental Studies, Nagasaki University |
Author_xml | – sequence: 1 givenname: Tomoki surname: Abe fullname: Abe, Tomoki – sequence: 2 givenname: Katsuya surname: Hirasaka fullname: Hirasaka, Katsuya – sequence: 3 givenname: Takeshi surname: Nikawa fullname: Nikawa, Takeshi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28344752$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UU1r3DAQFSWhSdO99Rz22EO8sfWtS6AsaRsayCU5C8ke72qxpY3ldei_77TZLkkgQjAj9Oa9x5tP5CimCIR8qcoFp8xcPm2axaQXgS2M-kBOK8N1YZjQRy_6EzLLeVPi4UJKZj6SE6oZ50rQU_LrJk6pm6CHOM5TO1_6rvBFD01wIzTz3tVD2q7dCuYhunoMkxtDivjAm3cd1gFyyKOLNXwmx63rMsz29Yw8fL--X_4sbu9-3Cy_3RY1l3osRNM2SlIlZCu8UACVlJp6akrBS2Og8dx7T71iDddV2yr0DaVCy8ZJAMrOyNUz73bn0WmN1gfX2e0Qejf8tskF-_onhrVdpckKxrWkAgm-7gmG9LiDPNo-5Bq6zkVIu2wrrSvODRUlQs9fah1E_ieIgItnAAaV8wDtAVKV9u-OLO7ITtoGZo1COH0Dr8P4L1N0Grr3hth-aJ3i6jHE1UFEK4WhSiNKrrkRgmtRYafR-h9MbabW |
CitedBy_id | crossref_primary_10_2147_DMSO_S273780 crossref_primary_10_1016_j_bbrc_2021_07_093 crossref_primary_10_1186_s12967_021_03069_w crossref_primary_10_1080_13543776_2024_2412567 crossref_primary_10_3390_ijms21176335 crossref_primary_10_1155_2022_3968494 crossref_primary_10_1186_s12964_021_00735_w crossref_primary_10_3389_fnut_2024_1445080 crossref_primary_10_3389_fimmu_2024_1297893 crossref_primary_10_3390_ijms241310419 crossref_primary_10_1126_sciadv_abd3359 |
Cites_doi | 10.1038/ng.584 10.1016/j.cell.2007.08.002 10.2337/db06-1027 10.1074/jbc.M606781200 10.1038/18050 10.1038/ni1299 10.1084/jem.20021686 10.1016/j.metabol.2013.06.008 10.5551/jat.3368 10.2337/db06-1768 10.1038/nm1607 10.1007/978-1-4419-1603-7_6 10.1172/JCI24335 10.1073/pnas.1110712108 10.1038/ni.1908 10.1074/jbc.M706762200 10.1007/s00125-012-2710-2 10.4172/2155-6156.1000364 10.1016/j.molcel.2010.10.004 10.1189/jlb.3HI0115-018R 10.1016/j.yexcr.2005.07.015 10.1038/nm1185 10.1038/ng927 10.1016/j.imbio.2015.06.016 10.1038/nm.4141 10.1111/j.1476-5381.2012.02097.x 10.1155/2015/340520 10.1111/j.1365-2567.2008.02892.x 10.1189/jlb.1012487 10.1161/01.ATV.0000251 608.09329.9a 10.1038/35067100 10.1172/JCI28898 10.1161/01.CIR.0000 091339.70120.53 10.1038/nm.1964 10.1016/S1074-7613(00)80273-3 10.1097/MOL.0b013e32832fa5c4 10.1172/JCI19246 10.1016/j.cmet.2007. 09.011 10.1038/sj.onc.1202499 10.2337/db09-1403 10.1126/science.1227568 10.1038/nm.2851 10.1016/j.cmet.2009.09.006 10.1016/S1097-2765(00)80231-2 10.1038/nri722 10.2337/db11-1300 10.2337/db12-0677 10.1146/annurev.biochem.70.1.503 10.1038/sj.onc.1202411 10.1038/ni1066 10.4049/jimmunol.1500859 10.1016/j.bbrc.2008.01.032 10.1016/S0070-2153(05)68005-2 10.1128/MCB.01347-08 10.1096/fj.12-205583 10.1371/journal.pone.0088704 10.1084/jem.20151932 10.4049/jimmunol.174.3.1472 10.1016/j.bbadis.2013.05.017 10.1038/ni855 |
ContentType | Journal Article |
Copyright | The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. 2017 |
Copyright_xml | – notice: The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. 2017 |
DBID | 2RA 92L CQIGP ~WA AAYXX CITATION NPM 7X8 5PM |
DOI | 10.4239/wjd.v8.i3.97 |
DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库- 镜像站点 CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance |
EISSN | 1948-9358 |
EndPage | 103 |
ExternalDocumentID | PMC5348625 28344752 10_4239_wjd_v8_i3_97 87746869504849554851484850 |
Genre | Journal Article Review |
GroupedDBID | --- 2RA 53G 5VR 8WL 92L AAKDD ADBBV AFUIB ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CCEZO CHBEP CIEJG CQIGP CW9 DIK FA0 GX1 HYE M~E OK1 RNS RPM ~WA AAYXX CITATION NPM 7X8 5PM |
ID | FETCH-LOGICAL-c468t-5dfd762756f5b57ee16682b29054099edb4bbb2b73d481ff7045e078349a6ee23 |
ISSN | 1948-9358 |
IngestDate | Thu Aug 21 18:04:57 EDT 2025 Fri Jul 11 02:49:20 EDT 2025 Thu Jan 02 22:22:01 EST 2025 Tue Jul 01 03:34:00 EDT 2025 Thu Apr 24 22:58:32 EDT 2025 Wed Feb 14 10:03:13 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 3 |
Keywords | Obesity Insulin resistance Casitas b-lineage lymphoma-b Toll-like receptor 4 Macrophage |
Language | English |
License | This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c468t-5dfd762756f5b57ee16682b29054099edb4bbb2b73d481ff7045e078349a6ee23 |
Notes | Tomoki Abe;Katsuya Hirasaka;Takeshi Nikawa;Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School;Graduate School of Fisheries Science and Environmental Studies, Nagasaki University ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Telephone: +81-88-6339248 Fax: +81-88-6337086 Author contributions: Abe T generated the figures and wrote the manuscript; Hirasaka K and Nikawa T specified the aims of the editorial and assisted in writing the manuscript. Correspondence to: Takeshi Nikawa, MD, PhD, Professor, Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan. nikawa@tokushima-u.ac.jp |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5348625 |
PMID | 28344752 |
PQID | 1881449250 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5348625 proquest_miscellaneous_1881449250 pubmed_primary_28344752 crossref_primary_10_4239_wjd_v8_i3_97 crossref_citationtrail_10_4239_wjd_v8_i3_97 chongqing_primary_87746869504849554851484850 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-03-15 |
PublicationDateYYYYMMDD | 2017-03-15 |
PublicationDate_xml | – month: 03 year: 2017 text: 2017-03-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | World journal of diabetes |
PublicationTitleAlternate | World Journal of Diabetes |
PublicationYear | 2017 |
Publisher | Baishideng Publishing Group Inc |
Publisher_xml | – name: Baishideng Publishing Group Inc |
References | ref13 ref57 ref12 ref56 ref15 ref59 ref14 ref58 ref53 ref52 ref11 ref55 ref10 ref54 ref17 ref16 ref19 ref18 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref60 ref61 12118252 - Nat Genet. 2002 Aug;31(4):391-4 22618766 - Diabetes. 2012 Jun;61(6):1315-22 17053832 - J Clin Invest. 2006 Nov;116(11):3015-25 22983634 - Diabetologia. 2012 Dec;55(12):3350-8 20103702 - Diabetes. 2010 Apr;59(4):916-25 26180583 - Oxid Med Cell Longev. 2015;2015:340520 10086340 - Oncogene. 1999 Mar 11;18(10 ):1855-66 20453840 - Nat Genet. 2010 Jun;42(6):495-7 22842477 - Nat Med. 2012 Aug;18(8):1279-85 18624726 - Immunology. 2009 Feb;126(2):233-45 26162692 - Immunobiology. 2015 Nov;220(11):1246-54 25934927 - J Leukoc Biol. 2015 Oct;98(4):467-77 17601987 - Diabetes. 2007 Oct;56(10 ):2511-22 23707515 - Biochim Biophys Acta. 2014 Mar;1842(3):446-62 10635327 - Mol Cell. 1999 Dec;4(6):1029-40 17618294 - Nat Med. 2007 Aug;13(8):920-6 20639876 - Nat Immunol. 2010 Aug;11(8):734-42 15107846 - Nat Immunol. 2004 May;5(5):495-502 16341265 - J Clin Invest. 2006 Jan;116(1):115-24 16415872 - Nat Immunol. 2006 Feb;7(2):148-55 17392283 - J Biol Chem. 2007 Jun 1;282(22):16042-53 14517163 - Circulation. 2003 Oct 14;108(15):1822-30 20179360 - J Atheroscler Thromb. 2010 Mar 31;17(3):219-28 17259398 - Diabetes. 2007 Feb;56(2):506-12 16124998 - Curr Top Dev Biol. 2005;68:123-48 15661906 - J Immunol. 2005 Feb 1;174(3):1472-8 19546233 - Mol Cell Biol. 2009 Sep;29(17 ):4798-811 12415267 - Nat Immunol. 2002 Dec;3(12 ):1192-9 19883619 - Cell Metab. 2009 Nov;10(5):419-29 11910892 - Nat Rev Immunol. 2002 Feb;2(2):106-15 22776094 - Br J Pharmacol. 2012 Nov;167(5):990-9 26392463 - J Immunol. 2015 Nov 1;195(9):4415-25 19633658 - Nat Med. 2009 Aug;15(8):914-20 12771181 - J Exp Med. 2003 Jun 2;197(11):1511-24 20965425 - Mol Cell. 2010 Oct 22;40(2):323-32 17803912 - Cell. 2007 Sep 7;130(5):906-17 8986718 - Immunity. 1996 Dec;5(6):591-604 16137676 - Exp Cell Res. 2005 Nov 1;310(2):303-10 24551137 - PLoS One. 2014 Feb 13;9(2):e88704 23325923 - J Leukoc Biol. 2013 Apr;93(4):611-22 27428899 - Nat Med. 2016 Aug;22(8):906-14 23223452 - Science. 2013 Jan 11;339(6116):218-22 19625959 - Curr Opin Lipidol. 2009 Oct;20(5):379-85 14679176 - J Clin Invest. 2003 Dec;112(12):1796-808 20665200 - Adv Exp Med Biol. 2010;667:59-68 10078535 - Nature. 1999 Mar 4;398(6722):84-90 11283727 - Nat Rev Mol Cell Biol. 2001 Apr;2(4):294-307 17983584 - Cell Metab. 2007 Nov;6(5):386-97 11395416 - Annu Rev Biochem. 2001;70:503-33 23953944 - Metabolism. 2013 Nov;62(11):1623-32 17916553 - J Biol Chem. 2007 Nov 30;282(48):35279-92 18201552 - Biochem Biophys Res Commun. 2008 Mar 28;368(1):37-42 10022120 - Oncogene. 1999 Feb 4;18(5):1147-56 22562833 - FASEB J. 2012 Aug;26(8):3282-91 15685170 - Nat Med. 2005 Feb;11(2):191-8 27432944 - J Exp Med. 2016 Jul 25;213(8):1555-70 22158902 - Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20579-84 23349502 - Diabetes. 2013 Jun;62(6):1957-69 17082484 - Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):84-91 |
References_xml | – ident: ref1 – ident: ref21 doi: 10.1038/ng.584 – ident: ref58 doi: 10.1016/j.cell.2007.08.002 – ident: ref22 doi: 10.2337/db06-1027 – ident: ref55 doi: 10.1074/jbc.M606781200 – ident: ref15 doi: 10.1038/18050 – ident: ref50 doi: 10.1038/ni1299 – ident: ref14 doi: 10.1084/jem.20021686 – ident: ref40 doi: 10.1016/j.metabol.2013.06.008 – ident: ref43 doi: 10.5551/jat.3368 – ident: ref35 doi: 10.2337/db06-1768 – ident: ref53 doi: 10.1038/nm1607 – ident: ref24 doi: 10.1007/978-1-4419-1603-7_6 – ident: ref38 doi: 10.1172/JCI24335 – ident: ref18 doi: 10.1073/pnas.1110712108 – ident: ref8 doi: 10.1038/ni.1908 – ident: ref31 doi: 10.1074/jbc.M706762200 – ident: ref39 doi: 10.1007/s00125-012-2710-2 – ident: ref59 doi: 10.4172/2155-6156.1000364 – ident: ref2 doi: 10.1016/j.molcel.2010.10.004 – ident: ref41 doi: 10.1189/jlb.3HI0115-018R – ident: ref44 doi: 10.1016/j.yexcr.2005.07.015 – ident: ref32 doi: 10.1038/nm1185 – ident: ref19 doi: 10.1038/ng927 – ident: ref57 doi: 10.1016/j.imbio.2015.06.016 – ident: ref10 doi: 10.1038/nm.4141 – ident: ref56 doi: 10.1111/j.1476-5381.2012.02097.x – ident: ref3 doi: 10.1155/2015/340520 – ident: ref28 doi: 10.1111/j.1365-2567.2008.02892.x – ident: ref46 doi: 10.1189/jlb.1012487 – ident: ref26 doi: 10.1161/01.ATV.0000251 608.09329.9a – ident: ref12 doi: 10.1038/35067100 – ident: ref25 doi: 10.1172/JCI28898 – ident: ref60 doi: 10.1161/01.CIR.0000 091339.70120.53 – ident: ref7 doi: 10.1038/nm.1964 – ident: ref45 doi: 10.1016/S1074-7613(00)80273-3 – ident: ref54 doi: 10.1097/MOL.0b013e32832fa5c4 – ident: ref23 doi: 10.1172/JCI19246 – ident: ref34 doi: 10.1016/j.cmet.2007. 09.011 – ident: ref13 doi: 10.1038/sj.onc.1202499 – ident: ref42 doi: 10.2337/db09-1403 – ident: ref33 doi: 10.1126/science.1227568 – ident: ref29 doi: 10.1038/nm.2851 – ident: ref27 doi: 10.1016/j.cmet.2009.09.006 – ident: ref16 doi: 10.1016/S1097-2765(00)80231-2 – ident: ref37 doi: 10.1038/nri722 – ident: ref5 doi: 10.2337/db11-1300 – ident: ref36 doi: 10.2337/db12-0677 – ident: ref11 doi: 10.1146/annurev.biochem.70.1.503 – ident: ref17 doi: 10.1038/sj.onc.1202411 – ident: ref49 doi: 10.1038/ni1066 – ident: ref52 doi: 10.4049/jimmunol.1500859 – ident: ref20 doi: 10.1016/j.bbrc.2008.01.032 – ident: ref4 doi: 10.1016/S0070-2153(05)68005-2 – ident: ref61 doi: 10.1128/MCB.01347-08 – ident: ref51 doi: 10.1096/fj.12-205583 – ident: ref30 doi: 10.1371/journal.pone.0088704 – ident: ref9 doi: 10.1084/jem.20151932 – ident: ref48 doi: 10.4049/jimmunol.174.3.1472 – ident: ref6 doi: 10.1016/j.bbadis.2013.05.017 – ident: ref47 doi: 10.1038/ni855 – reference: 17983584 - Cell Metab. 2007 Nov;6(5):386-97 – reference: 12415267 - Nat Immunol. 2002 Dec;3(12 ):1192-9 – reference: 16137676 - Exp Cell Res. 2005 Nov 1;310(2):303-10 – reference: 23707515 - Biochim Biophys Acta. 2014 Mar;1842(3):446-62 – reference: 15661906 - J Immunol. 2005 Feb 1;174(3):1472-8 – reference: 11395416 - Annu Rev Biochem. 2001;70:503-33 – reference: 8986718 - Immunity. 1996 Dec;5(6):591-604 – reference: 17392283 - J Biol Chem. 2007 Jun 1;282(22):16042-53 – reference: 15107846 - Nat Immunol. 2004 May;5(5):495-502 – reference: 12118252 - Nat Genet. 2002 Aug;31(4):391-4 – reference: 17618294 - Nat Med. 2007 Aug;13(8):920-6 – reference: 20103702 - Diabetes. 2010 Apr;59(4):916-25 – reference: 10635327 - Mol Cell. 1999 Dec;4(6):1029-40 – reference: 11910892 - Nat Rev Immunol. 2002 Feb;2(2):106-15 – reference: 14679176 - J Clin Invest. 2003 Dec;112(12):1796-808 – reference: 20179360 - J Atheroscler Thromb. 2010 Mar 31;17(3):219-28 – reference: 22983634 - Diabetologia. 2012 Dec;55(12):3350-8 – reference: 10022120 - Oncogene. 1999 Feb 4;18(5):1147-56 – reference: 12771181 - J Exp Med. 2003 Jun 2;197(11):1511-24 – reference: 19633658 - Nat Med. 2009 Aug;15(8):914-20 – reference: 10078535 - Nature. 1999 Mar 4;398(6722):84-90 – reference: 19546233 - Mol Cell Biol. 2009 Sep;29(17 ):4798-811 – reference: 17082484 - Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):84-91 – reference: 20639876 - Nat Immunol. 2010 Aug;11(8):734-42 – reference: 23325923 - J Leukoc Biol. 2013 Apr;93(4):611-22 – reference: 18624726 - Immunology. 2009 Feb;126(2):233-45 – reference: 22562833 - FASEB J. 2012 Aug;26(8):3282-91 – reference: 27432944 - J Exp Med. 2016 Jul 25;213(8):1555-70 – reference: 17259398 - Diabetes. 2007 Feb;56(2):506-12 – reference: 11283727 - Nat Rev Mol Cell Biol. 2001 Apr;2(4):294-307 – reference: 17053832 - J Clin Invest. 2006 Nov;116(11):3015-25 – reference: 20665200 - Adv Exp Med Biol. 2010;667:59-68 – reference: 23349502 - Diabetes. 2013 Jun;62(6):1957-69 – reference: 14517163 - Circulation. 2003 Oct 14;108(15):1822-30 – reference: 23953944 - Metabolism. 2013 Nov;62(11):1623-32 – reference: 24551137 - PLoS One. 2014 Feb 13;9(2):e88704 – reference: 22842477 - Nat Med. 2012 Aug;18(8):1279-85 – reference: 17916553 - J Biol Chem. 2007 Nov 30;282(48):35279-92 – reference: 18201552 - Biochem Biophys Res Commun. 2008 Mar 28;368(1):37-42 – reference: 22618766 - Diabetes. 2012 Jun;61(6):1315-22 – reference: 22158902 - Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20579-84 – reference: 16415872 - Nat Immunol. 2006 Feb;7(2):148-55 – reference: 20965425 - Mol Cell. 2010 Oct 22;40(2):323-32 – reference: 23223452 - Science. 2013 Jan 11;339(6116):218-22 – reference: 22776094 - Br J Pharmacol. 2012 Nov;167(5):990-9 – reference: 10086340 - Oncogene. 1999 Mar 11;18(10 ):1855-66 – reference: 17803912 - Cell. 2007 Sep 7;130(5):906-17 – reference: 26392463 - J Immunol. 2015 Nov 1;195(9):4415-25 – reference: 26180583 - Oxid Med Cell Longev. 2015;2015:340520 – reference: 25934927 - J Leukoc Biol. 2015 Oct;98(4):467-77 – reference: 19883619 - Cell Metab. 2009 Nov;10(5):419-29 – reference: 15685170 - Nat Med. 2005 Feb;11(2):191-8 – reference: 27428899 - Nat Med. 2016 Aug;22(8):906-14 – reference: 19625959 - Curr Opin Lipidol. 2009 Oct;20(5):379-85 – reference: 16341265 - J Clin Invest. 2006 Jan;116(1):115-24 – reference: 20453840 - Nat Genet. 2010 Jun;42(6):495-7 – reference: 17601987 - Diabetes. 2007 Oct;56(10 ):2511-22 – reference: 16124998 - Curr Top Dev Biol. 2005;68:123-48 – reference: 26162692 - Immunobiology. 2015 Nov;220(11):1246-54 |
SSID | ssj0000456639 |
Score | 2.0631907 |
SecondaryResourceType | review_article |
Snippet | Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance(IR).... Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance (IR).... |
SourceID | pubmedcentral proquest pubmed crossref chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 97 |
SubjectTerms | Minireviews |
Title | Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance |
URI | http://lib.cqvip.com/qk/71418X/201703/87746869504849554851484850.html https://www.ncbi.nlm.nih.gov/pubmed/28344752 https://www.proquest.com/docview/1881449250 https://pubmed.ncbi.nlm.nih.gov/PMC5348625 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgSIgXxDcdHwoSPEFK49iJ_YimjQFbeUmlvll246yhW8LWdBP89ZztfI4-DF6s1HFty3e-3J3vfkbo7YRpokIufUkW1CdYBbDnzCk85pmikqjAJtIeT6PDGfk6p_PmovE6u6RS48XvrXkl_0NVqAO6mizZf6Bs2ylUwDPQF0qgMJQ3ovGXAoSLBfy25_l76tRXvs0FMXrkmTTXcy1NUE5emPwF5301Ho4mAh1sbaM_NoSvlVQXYNPDlGgctN1ZkcPqLc_KVd45ry_kWq7qFLNqvfnVSvxpvpJX9kUiV3q9zPu-Bvh-mcA12hOPnIB4DB3Y-lhvqatlKuuxTtiTjy4W97rYNiCEsNZXP9LxJRvn4dg1G6JjT7-Lg9nRkUj258ltdAfHsT2W_zwPWp-aUU8je3lcOymX62AG-Njv3iBpLMvi5Bz0g6FG8peZcT1atqd-JA_Q_dpu8D45JniIbuniEbp7XEdGPEbferzglZk35AWv4wWvzwvww6t5wet44QmaHewne4d-fVGGvyARq3yaZmlsgfwzqmisdRBFDCvMjT7OuU4VUUphFYcpYUGWxbBQ2pzfEi4jrXH4FO0UZaGfI4-noLLFOI01C0g2wQqWNM0iPsmIhn-rEfrQLpz46QBRBOxumEfEKXwOwOAGIxjUcAblZITeN2srFjXovLn75FSA8WmoIoAq4pKJPBQ8HqF3beum7-3t3jRkEiANzRGXLHS5WYuAwbQN3iaM_MyRre0JM4tuiUcoHhC0bWCQ1odvinxpEddpSMDyp7s3GPcFutftnJdop7rY6Fegt1bqtWXWP43Um-4 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+Cbl-b-mediated+macrophage+inactivation+in+insulin+resistance&rft.jtitle=World+journal+of+diabetes&rft.au=Abe%2C+Tomoki&rft.au=Hirasaka%2C+Katsuya&rft.au=Nikawa%2C+Takeshi&rft.date=2017-03-15&rft.issn=1948-9358&rft.eissn=1948-9358&rft.volume=8&rft.issue=3&rft.spage=97&rft_id=info:doi/10.4239%2Fwjd.v8.i3.97&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F71418X%2F71418X.jpg |